Automation Friendly Reagent Reservoirs

INTEGRA Biosciences has expanded its range of products to include 8 row and 12 column automation friendly reagent reservoirs, offering a greater variety of reservoir dimensions to suit the increasing diverse applications of automated workstations.

Laboratory automation is increasingly important, driving a need for reagent reservoirs that are compatible with industry-standard liquid handling platforms. The latest additions to the INTEGRA range of automation friendly reagent reservoirs are especially designed for use with the VIAFLO 96, VIAFLO 384, and MINI 96 handheld electronic pipettes, complementing the popular 150 ml and 300 ml open well options. The 12 column reservoir offers a capacity of 21 ml per column and the 8 row version 32 ml per row. Both configurations employ INTEGRA’s innovative SureFlo™ anti-sealing array technology to achieve the lowest possible dead volumes. The new microplate-format reservoirs are available in polystyrene with a polypropylene alternative for improved chemical compatibility. Supplied in cases of 30 individual sterile units, the reservoirs are ideal for use with all SLAS footprint automated liquid handling platforms.

Visit the INTEGRA Biosciences website to learn more.

About INTEGRA Biosciences

INTEGRA Biosciences is a leading provider of high-quality laboratory tools and consumables for liquid handling and media preparation. The company is committed to creating innovative solutions which fulfil the needs of its customers in research, diagnostics and quality control within the life sciences markets and medical sector. Today, INTEGRA innovative laboratory products are widely used all around the world. More than 100 distribution partners form a worldwide sales network providing responsive and competent services to customers. These distribution partners are supported by a highly motivated and experienced team of specialists at the company headquarters in Zizers, Switzerland and Hudson, NH, USA. INTEGRA is an ISO 9001 certified company.

Recent news from INTEGRA Biosciences